Document is current
Any future updates will be listed below
-
Authors
Elwing, Jean M.
Krishnan, Mrinalini
Parikh, Kishan S.
Sargent, Therese
Wu, Sheryl https://orcid.org/0000-0001-8314-4787
Benninger, Christina https://orcid.org/0009-0000-4057-0540
Doad, Gurinderpal https://orcid.org/0009-0006-4577-1601
Hill, Wendy
Oswald, Charlotte
Bridge, Daisy C.
O’Donovan, Peter
Maranes, Luis Val
Miller, Chad
-
Funding
Funding for this research was provided by:
Johnson and Johnson
- License Information
-
More Information
Article History
Received: 29 October 2025
Accepted: 2 January 2026
First Online: 12 February 2026
Declarations
:
: Christina Benninger, Gurinderpal Doad, and Wendy Hill are employees and shareholders of Johnson & Johnson. Daisy Bridge, Peter O’Donovan, Charlotte Oswald, and Luis Val Maranes are employees of Adelphi Values PROVE, who were contracted by Johnson & Johnson to conduct this research. Jean M Elwing has served as a consultant for Aerovate, Gossamer Bio, Insmed, Johnson & Johnson, Liquidia, Merck, Pulmovant, and United Therapeutics. She has also participated in clinical research studies funded by Acceleron/Merck, Aerovate, Altavant, Bayer, Gossamer Bio, Johnson & Johnson, Lung LLC, Pharmosa/Liquidia, Pulmovant, and United Therapeutics. Mrinalini Krishnan has affiliations with Johnson & Johnson, including service on the Speakers Bureau, Scientific Advisory Board, and as a consultant. Mrinalini Krishnan also serves on the Speakers Bureau for Liquidia and serves as a consultant and Advisory Board member for Liquidia, NorthGauge HealthCare Advisors, and United Therapeutics. Kishan S Parikh is a member of the Advisory Committee for Johnson & Johnson and Merck, as well as being a member of Advisory Boards for Merck and United Therapeutics. Sheryl Wu is a member of the Speaker Bureau for Johnson & Johnson and Merck, as well as a member of Advisory Boards for Johnson & Johnson, Liquidia and Merck. Therese Sargent has received consultancy fees from Johnson & Johnson. Chad Miller reports consulting fees and speaking fees from United Therapeutics Corporation and Johnson & Johnson; speaking fees from Bayer AG; and consulting fees from Merck Pharmaceutical (HK) Ltd.
: This study is a SLR and, as such, involved the analysis and synthesis of existing published research. No new data involving human participants or animals were collected, and therefore, ethical approval was not required. All sources and studies included in this review have been appropriately cited and acknowledged, ensuring respect for intellectual property and adherence to academic integrity standards.
